
### [NCIT:C95909](http://purl.obolibrary.org/obo/NCIT_C95909)
**Label:** Preinvasive Neoplasm of the Ampullary Region

**Subclasses:** [NCIT:C6659](http://purl.obolibrary.org/obo/NCIT_C6659) (Ampulla of Vater Tubular Adenoma), [NCIT:C95914](http://purl.obolibrary.org/obo/NCIT_C95914) (Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with Low Grade Dysplasia), [NCIT:C6658](http://purl.obolibrary.org/obo/NCIT_C6658) (Ampulla of Vater Villous Adenoma), [NCIT:C95913](http://purl.obolibrary.org/obo/NCIT_C95913) (Ampullary Noninvasive Papillary Neoplasm, Pancreatobiliary Type), [NCIT:C27412](http://purl.obolibrary.org/obo/NCIT_C27412) (Ampulla of Vater Tubulovillous Adenoma), [NCIT:C6657](http://purl.obolibrary.org/obo/NCIT_C6657) (Ampulla of Vater Intestinal-Type Adenoma), [NCIT:C95918](http://purl.obolibrary.org/obo/NCIT_C95918) (Ampullary Flat Intraepithelial Neoplasia, High Grade), [NCIT:C95915](http://purl.obolibrary.org/obo/NCIT_C95915) (Ampullary Noninvasive Pancreatobiliary Papillary Neoplasm with High Grade Dysplasia), 

**Class expressions from DL-Learner:**

- Thing 53.35%
- [NCIT:C54201](http://purl.obolibrary.org/obo/NCIT_C54201) (Exophytic Papillary Lesion) 52.94%
- [NCIT:C41361](http://purl.obolibrary.org/obo/NCIT_C41361) (KRAS Gene Mutation) 52.94%
- [NCIT:C40560](http://purl.obolibrary.org/obo/NCIT_C40560) (Exophytic Polypoid Lesion) 52.94%
- [NCIT:C36683](http://purl.obolibrary.org/obo/NCIT_C36683) (APC Gene Inactivation) 52.94%
- [NCIT:C36329](http://purl.obolibrary.org/obo/NCIT_C36329) (TP53 Gene Inactivation) 52.94%
- [NCIT:C25785](http://purl.obolibrary.org/obo/NCIT_C25785) (KRAS Gene) 52.94%
- [NCIT:C17567](http://purl.obolibrary.org/obo/NCIT_C17567) (APC Gene) 52.94%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C36118](http://purl.obolibrary.org/obo/NCIT_C36118) (In Situ Lesion))) 52.94%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) 38.30%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 38.30%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 38.30%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 38.30%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 38.30%
- [NCIT:C36027](http://purl.obolibrary.org/obo/NCIT_C36027) (Non-Invasive Lesion) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 38.30%


